Novo Nordisk's total assets for Q1 2025 were kr489.16B, an increase of 5.02% from the previous quarter. NVO total liabilities were kr350.62B for the fiscal quarter, a 8.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.